Mitotech S.A. Developing a Dry Eye Treatment has been Granted Two U.S....

Mitotech S.A., a Luxembourg based clinical stage biotechnology company developing a Dry Eye treatment announces issuance of two U.S. patents for pharmaceutical formulations of its lead compound SkQ1(PRWeb January 05, 2017)Read the full story at http://www.prweb.com/releases/2017/01/prweb13956329.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news